Chemotherapy and Immunotherapy in Urologic Oncology

Edouard J. Trabulsi Director, Multidisciplinary Genitourinary Oncology Center Director, Division of Urologic Oncology, Department of Urology Co-Director, Prostate Diagnostic Center Professor and Vice Chair of Research Department of Urology Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia, PA USA Costas D. Lallas Professor and Vice Chair of Academic Affairs Department of Urology Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia, PA USA Anne E. Lizardi-Calvaresi Director of Clinical Operations Urology Nurse Practitioner Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia, PA USA

Introduction: Integration of APP into Urologic Oncology Practice.- Overview and Active Surveillance of Prostate Cancer.- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer.- Radical Prostatectomy and Survivorship after Radical Prostatectomy.- Multimodal Treatment Plans in Prostate Cancer.- Radiotherapy for Prostate Cancer.- Androgen Deprivation Treatment.- Second Generation Androgen Targeted Agents.- Chemotherapy and prostate cancer.- Radiopharmaceuticals for Prostate Cancer.- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer.- Bladder Cancer.- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma.- Bladder Cancer: Muscle Invasive Disease.- Chemoradiation Bladder Preservation.- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy.- Immunotherapy for Metastatic Urothelial Cancer.- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma.- Upper Tract Urothelial Carcinoma.- KidneyCancer and Its Treatment.- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma.- Immune Therapies for Metastatic Kidney Cancer.- Novel Therapies for Renal Cell Carcinoma.- Testicular Cancer.- Penile Cancer.